Literature DB >> 7545460

The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.

N Debili1, F Wendling, A Katz, J Guichard, J Breton-Gorius, P Hunt, W Vainchenker.   

Abstract

Previously, it was believed that megakaryocytopoiesis was regulated by two types of humoral factors: megakaryocyte colony-stimulating factor (MK-CSF), which acts on progenitors inducing their proliferation, and thrombopoietin (TPO), a megakaryocyte(s) (MK) maturational factor that induces platelet formation. The recently cloned Mpl-ligand (Mpl-L) seems to have both properties in vivo and in vitro and has also been called TPO. However, it cannot be excluded that a part of these activities is due to a synergistic effect with growth factors present in the serum or synthesized by accessory cells. To delineate the precise TPO (Mpl-L) biologic activities, we performed serum-free cultures at limiting cell dilution. Target cells were adult human marrow CD34+CD41+ cells, which represent a highly selected population of late MK progenitor or transitional cells. Cells were purified using a flow cytometer equipped with an automatic cloning design unit. We determined that the recombinant molecule had a biologic activity that reached a plateau at 10 ng/mL. At this concentration, a linear relationship between the average MK number per well and the number of cells seeded (between 1 to 50 cells per well) was observed. At one cell per well, 60% of the wells contained a single MK at day 5 of culture. Half of these wells contained only one large MK, whereas the other half contained several MK (up to 25), demonstrating that TPO has direct proliferative biologic activity. In contrast, at limiting dilution, none of the other cytokines tested (stem cell factor [SCF], interleukin-6 [IL-6], and erythropoietin [Epo]) were effective, whereas IL-3 showed a mild effect. However, a combination of SCF plus IL-6 plus IL-3 produced similar results as TPO alone. Addition of the other cytokines to TPO did not enhance the cloning efficiency of the CD34+CD41+ cells but increased twofold the average number of MKs per clone. MKs reached a ploidy of 32N and 64N in the presence of TPO. The mean ploidy value was approximately 6 and was not modified by addition of the other cytokines. At the ultrastructural level, a majority of the MKs showed maturational defects related to an imbalance between the synthesis of alpha-granules and demarcation membranes. However, a fraction (about 30%) had a cytoplasmic maturation that exactly mimicked that of marrow MKs. In addition, proplatelet-shedding MKs were observed in the cultures, even at limiting dilution. Such a result was not observed with any other individual cytokines, including the combination of three cytokines.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545460

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins.

Authors:  Liyan Pang; Hai-Hui Xue; Gabor Szalai; Xun Wang; Yuhuan Wang; Dennis K Watson; Warren J Leonard; Gerd A Blobel; Mortimer Poncz
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

Review 2.  Megakaryocyte biology and related disorders.

Authors:  Liyan Pang; Mitchell J Weiss; Mortimer Poncz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 3.  Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation.

Authors:  Tianyu Guo; Xuejun Wang; Yigong Qu; Yu Yin; Tao Jing; Qing Zhang
Journal:  Stem Cell Investig       Date:  2015-02-14

4.  Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets.

Authors:  R Möhle; D Green; M A Moore; R L Nachman; S Rafii
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Adult human megakaryocyte-erythroid progenitors are in the CD34+CD38mid fraction.

Authors:  Chad Sanada; Juliana Xavier-Ferrucio; Yi-Chien Lu; Elizabeth Min; Ping-Xia Zhang; Siying Zou; Elaine Kang; Meng Zhang; Gazelle Zerafati; Patrick G Gallagher; Diane S Krause
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113

6.  Proliferation of human progenitor cells in a long-term culture system is more efficiently sustained by the addition of Flt-3 ligand or megakaryocyte growth and development factor than by Kit ligand.

Authors:  G Cartron; C Binet; O Hérault; C Cailliot; M C Bernard; M H Estienne; N Clément; Ph Colombat; J Domenech
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

7.  A role for cyclin D3 in the endomitotic cell cycle.

Authors:  J M Zimmet; D Ladd; C W Jackson; P E Stenberg; K Ravid
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

8.  Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice.

Authors:  Toshiaki Shirai; Alexey S Revenko; Justin Tibbitts; Anh T P Ngo; Annachiara Mitrugno; Laura D Healy; Jennifer Johnson; Erik I Tucker; Monica T Hinds; Lisa M Coussens; Owen J T McCarty; Brett P Monia; András Gruber
Journal:  Blood Adv       Date:  2019-10-22

9.  Covalently immobilized glycosaminoglycans enhance megakaryocyte progenitor expansion and platelet release.

Authors:  Vipuil Kishore; James F Eliason; Howard W T Matthew
Journal:  J Biomed Mater Res A       Date:  2011-01-25       Impact factor: 4.396

Review 10.  In vitro megakaryocyte production and platelet biogenesis: state of the art.

Authors:  Jo-Anna Reems; Nicolas Pineault; Sijie Sun
Journal:  Transfus Med Rev       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.